CoChat

Efficacy of Lactobacillus casei Shirota for patients with irritable bowel syndrome

Thijssen, Annemieke Y., Clemens, Cees H.M., Vankerckhoven, Vanessa, Goossens, Herman, Jonkers, Daisy M.A.E., Masclee, Ad A.M. · 2016 · European Journal of Gastroenterology & Hepatology
Cited by 45

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Abstract

BACKGROUND AND AIMS: Meta-analyses point to a modest but significant effect of probiotics on symptoms in irritable bowel syndrome (IBS). We aimed to assess the effect of the probiotic Lactobacillus casei Shirota (LcS) on symptoms and quality of life in IBS patients in a randomized, double-blind, placebo-controlled intervention study. MATERIALS AND METHODS: IBS patients (Rome II) between 18 and 65 years of age were included. The study consisted of an 8-week intervention period in which the participants received probiotic (LcS) or placebo twice daily, followed by an 8-week follow-up period. Symptom diaries and quality of life were scored at weeks 0, 8 and 16. The primary outcome parameter was a decrease of at least 30% in a composite mean symptom score (MSS) at week 8 on the basis of an intention-to-treat analysis. RESULTS: Thirty-nine individuals (67% women) were included in the probiotic group and 41 individuals (71% women) were included in the placebo group. After the intervention period, the mean relative improvement did not reach 30% for MSS or any individual symptom score. After follow-up (week 16), a mean improvement of at least 30% was achieved for MSS in the probiotic group, but no significant difference was found between both treatment groups (mean±SD: 34±7%; 13±8%, P=0.06). CONCLUSION: After probiotic treatment with LcS, no improvement of 30% in MSS was observed after 8 weeks.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/meg.0000000000000484

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 24 references

Cited by

See all 45

Metadata

Authors
Thijssen, A. Y., Clemens, C. H. M., Vankerckhoven, V., Goossens, H., Jonkers, D. M. A. E., & Masclee, A. A. M.
Venue
European Journal of Gastroenterology & Hepatology
Published
2016-01
Volume
28
Issue
1
Pages
8-14
ISSN
0954-691X (ISSN-L)
OpenAlex
W2402415519
Cited by
45
References
24
FWCI
2.68
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Efficacy of Lactobacillus casei Shirota for patients with irritable bowel syndrome. https://app.cochat.ai/papers/10.1097/meg.0000000000000484
The paper
Thijssen, A. Y., Clemens, C. H. M., Vankerckhoven, V., Goossens, H., Jonkers, D. M. A. E., & Masclee, A. A. M. (2016). Efficacy of Lactobacillus casei Shirota for patients with irritable bowel syndrome. European Journal of Gastroenterology & Hepatology. https://doi.org/10.1097/meg.0000000000000484

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.